Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Sara Tai

28 indexed publications match this author name.

ORCID: 0000-0002-8316-5796
OpenAlex: https://openalex.org/A5003939496

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 15 Receptor Pharmacology 12 Safety 11 Clinical Trial 7 Mechanism of Action 7 Treatment-Resistant Depression 6 Addiction 4 Neuroplasticity 4 Review Article 4 Animal Study 4 Chronic Pain 4 Randomized Controlled Trial 4

Journals

ClinicalTrials.gov 4 Biological Psychiatry 2 Frontiers in Psychiatry 2 Schizophrenia Research 1 American Journal of Psychiatry 1 Journal of CO2 Utilization 1 JAMA Network Open 1 bioRxiv 1

Publication history

Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive SymptomsClinicalTrials.gov · 2026-06-30 Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative reviewSchizophrenia Research · 2026-03-12 COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISUnknown journal · 2025-12-10 Sudden Loss of Consciousness Following Psilocybin IngestionAmerican Journal of Psychiatry · 2025-11-30 Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic SeizuresClinicalTrials.gov · 2025-08-20 Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-19 Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.Unknown journal · 2025-08-17 Is there mush-room to improve the environmental sustainability of psilocybin production?Journal of CO2 Utilization · 2025-06-09 13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-08 Psilocybin in Alcohol Use Disorder With Comorbid DepressionClinicalTrials.gov · 2025-03-18 Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04 Distinct classes of antidepressants commonly act to shape pallidal structure and function in micebioRxiv · 2024-09-23 Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distressResearch Square · 2024-09-17 Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case reportFrontiers in Psychiatry · 2024-07-15 WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male miceJournal of Hepatology · 2024-05-31 Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative studyScientific Reports · 2024-02-04 ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study DesignNeuromodulation Technology at the Neural Interface · 2023-05-31 118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-09 Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-04 The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10 Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathwayFungal Genetics and Biology · 2022-12-28 The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03 Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.Unknown journal · 2021-02-21 Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02 Effects of psilocin on the striatal monoamine contents in mice and ratsThe Pharmaceutical Society of Japan · 2020-01-31 MAGIC MUSHROOMS: from sacred entheogen to Class A drugEntertainment and Sports Law Journal · 2016-06-26 Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.Journal of psychopharmacology (Oxford, England) · 2013-12-31 Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of Clinical Psychiatry · 2006-10-31

Author directory